日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy of liposomal irinotecan + 5-FU/LV vs. S-1 in gemcitabine-refractory metastatic pancreatic cancer: a real-world study using inverse probability of treatment weighting

脂质体伊立替康+5-FU/LV与S-1治疗吉西他滨难治性转移性胰腺癌的疗效比较:一项采用逆概率加权法的真实世界研究

Imaoka, Hiroshi; Ikeda, Masafumi; Kobayashi, Satoshi; Ohba, Akihiro; Ueno, Masayuki; Suzuki, Yuko; Tsumura, Hidetaka; Kimura, Nana; Kawaguchi, Shinya; Kawamoto, Yasuyuki; Nakachi, Kohei; Tsuji, Kunihiro; Kobayashi, Noritoshi; Ashida, Reiko; Okano, Naohiro; Umemoto, Kumiko; Murohisa, Gou; Hosokawa, Ayumu; Asagi, Akinori; Nebiki, Hiroko; Suzuki, Rei; Terashima, Takeshi; Shibata, Ryusuke; Kawata, Kazuhito; Doi, Toshifumi; Ohyama, Hiroshi; Kitano, Yohei; Shioji, Kazuhiko; Okuyama, Hiroyuki; Naganuma, Atsushi; Negoro, Yuji; Sakamoto, Yasunari; Shimizu, Satoshi; Morizane, Chigusa; Ueno, Makoto; Furuse, Junji; Nagano, Hiroaki

Correction: Efficacy of liposomal irinotecan + 5-FU/LV vs. S-1 in gemcitabine-refractory metastatic pancreatic cancer: a real-world study using inverse probability of treatment weighting

更正:脂质体伊立替康+5-FU/LV与S-1治疗吉西他滨难治性转移性胰腺癌的疗效比较:一项采用逆概率加权法的真实世界研究

Imaoka, Hiroshi; Ikeda, Masafumi; Kobayashi, Satoshi; Ohba, Akihiro; Ueno, Masayuki; Suzuki, Yuko; Tsumura, Hidetaka; Kimura, Nana; Kawaguchi, Shinya; Kawamoto, Yasuyuki; Nakachi, Kohei; Tsuji, Kunihiro; Kobayashi, Noritoshi; Ashida, Reiko; Okano, Naohiro; Umemoto, Kumiko; Murohisa, Gou; Hosokawa, Ayumu; Asagi, Akinori; Nebiki, Hiroko; Suzuki, Rei; Terashima, Takeshi; Shibata, Ryusuke; Kawata, Kazuhito; Doi, Toshifumi; Ohyama, Hiroshi; Kitano, Yohei; Shioji, Kazuhiko; Okuyama, Hiroyuki; Naganuma, Atsushi; Negoro, Yuji; Sakamoto, Yasunari; Shimizu, Satoshi; Morizane, Chigusa; Ueno, Makoto; Furuse, Junji; Nagano, Hiroaki

Combination chemotherapy for older patients with unresectable biliary tract cancer: a prospective observational study using propensity-score matched analysis (JON2104-B)

老年不可切除胆道癌患者的联合化疗:一项采用倾向评分匹配分析的前瞻性观察研究(JON2104-B)

Kobayashi, Satoshi; Nakachi, Kohei; Yamamoto, Kouji; Ueno, Makoto; Maruki, Yuta; Ikezawa, Kenji; Terashima, Takeshi; Shimizu, Satoshi; Oshima, Kotoe; Tsuji, Kunihiro; Masaki, Yoshiharu; Tsumura, Hidetaka; Shibuki, Taro; Ozaka, Masato; Okano, Naohiro; Okamura, Yukiyasu; Umemoto, Kumiko; Satoh, Tatsunori; Kojima, Yasushi; Shioji, Kazuhiko; Nebiki, Hiroko; Doi, Toshifumi; Naganuma, Atsushi; Kataoka, Shigeki; Kita, Emiri; Asama, Hiroyuki; Tsuchiya, Kaoru; Unno, Michiaki; Ashida, Reiko; Matsumoto, Kazuyuki; Ohno, Izumi; Itoi, Takao; Negoro, Yuji; Sakamoto, Yasunari; Arima, Shiho; Asagi, Akinori; Okuyama, Hiroyuki; Komatsu, Yoshito; Kobayashi, Noritoshi; Nagano, Hiroaki; Furuse, Junji

Downregulation of 15-PGDH enhances MASH-HCC development via fatty acid-induced T-cell exhaustion

15-PGDH 下调通过脂肪酸诱导的 T 细胞耗竭增强 MASH-HCC 的发展

Xichen Hu, Tadahito Yasuda, Noriko Yasuda-Yosihara, Atsuko Yonemura, Terumasa Umemoto, Yutaka Nakachi, Kohei Yamashita, Takashi Semba, Kota Arima, Tomoyuki Uchihara, Akiho Nishimura, Luke Bu, Lingfeng Fu, Feng Wei, Jun Zhang, Yilin Tong, Huaitao Wang, Kazuya Iwamoto, Takaichi Fukuda, Hayato Nakagawa

Prevalence of psychological distress and associated factors among patients undergoing comprehensive genomic profiling testing: protocol for a multicentre, prospective, observational study

接受全面基因组分析检测的患者中心理困扰的患病率及其相关因素:一项多中心、前瞻性观察研究方案

Matsuoka, Ayumu; Fujimori, Maiko; Koyama, Takafumi; Sato, Ayako; Mori, Keita; Hirata, Makoto; Tanabe, Noriko; Nakachi, Kohei; Kato, Shunsuke; Okamoto, Hiroaki; Ogawa, Kohei; Komatsu, Hirokazu; Iwasaku, Masahiro; Miyaji, Tempei; Uchitomi, Yosuke

Rare case of idiopathic sclerosing cholangitis, which was difficult to distinguish from cholangiocarcinoma: A case report

罕见的特发性硬化性胆管炎病例报告,该病难以与胆管癌鉴别。

Shichi, Shunsuke; Einama, Takahiro; Suzuki, Mayu; Matsui, Hiroki; Kanazawa, Ryo; Shibuya, Kazuaki; Suzuki, Takashi; Matsuzawa, Fumihiko; Nakachi, Kohei; Hashimoto, Taku; Kondo, Nobuo; Abe, Hironori; Taketomi, Akinobu

Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients

GPC3衍生肽疫苗作为肝细胞癌患者佐剂疗法的II期研究

Sawada, Yu; Yoshikawa, Toshiaki; Ofuji, Kazuya; Yoshimura, Mayuko; Tsuchiya, Nobuhiro; Takahashi, Mari; Nobuoka, Daisuke; Gotohda, Naoto; Takahashi, Shinichiro; Kato, Yuichiro; Konishi, Masaru; Kinoshita, Taira; Ikeda, Masafumi; Nakachi, Kohei; Yamazaki, Naoya; Mizuno, Shoichi; Takayama, Tadatoshi; Yamao, Kenji; Uesaka, Katsuhiko; Furuse, Junji; Endo, Itaru; Nakatsura, Tetsuya

Peretinoin after curative therapy of hepatitis C-related hepatocellular carcinoma: a randomized double-blind placebo-controlled study

丙型肝炎相关肝细胞癌根治性治疗后使用培利替诺:一项随机双盲安慰剂对照研究

Okita, Kiwamu; Izumi, Namiki; Matsui, Osamu; Tanaka, Katsuaki; Kaneko, Shuichi; Moriwaki, Hisataka; Ikeda, Kenji; Osaki, Yukio; Numata, Kazushi; Nakachi, Kohei; Kokudo, Norihiro; Imanaka, Kazuho; Nishiguchi, Shuhei; Okusaka, Takuji; Nishigaki, Yoichi; Shiomi, Susumu; Kudo, Masatoshi; Ido, Kenichi; Karino, Yoshiyasu; Hayashi, Norio; Ohashi, Yasuo; Makuuchi, Masatoshi; Kumada, Hiromitsu

Phase I study of combination chemotherapy using sorafenib and transcatheter arterial infusion with cisplatin for advanced hepatocellular carcinoma

索拉非尼联合顺铂经导管动脉灌注化疗治疗晚期肝细胞癌的I期研究

Hagihara, Atsushi; Ikeda, Masafumi; Ueno, Hideki; Morizane, Chigusa; Kondo, Shunsuke; Nakachi, Kohei; Mitsunaga, Shuichi; Shimizu, Satoshi; Kojima, Yasushi; Suzuki, Eiichiro; Katayama, Kazuhiro; Imanaka, Kazuho; Tamai, Chie; Inaba, Yoshitaka; Sato, Yozo; Kato, Mina; Okusaka, Takuji

Phase I study on the safety, pharmacokinetic profile, and efficacy of the combination of TSU-68, an oral antiangiogenic agent, and S-1 in patients with advanced hepatocellular carcinoma.

针对晚期肝细胞癌患者,开展 TSU-68(一种口服抗血管生成药物)与 S-1 联合用药的安全性、药代动力学特征和疗效的 I 期研究

Ikeda Masafumi, Shiina Shuichiro, Nakachi Kohei, Mitsunaga Shuichi, Shimizu Satoshi, Kojima Yasushi, Ueno Hideki, Morizane Chigusa, Kondo Shunsuke, Sakamoto Yasunari, Asaoka Yoshinari, Tateishi Ryosuke, Koike Kazuhiko, Arioka Hitoshi, Okusaka Takuji